Episode 24
In this episode of the Ori Spotlight Podcast Jason C. Foster is joined by Matthew Durdy, CEO at the Cell and Gene Therapy Catapult. They talk about how the CGT Catapult bridges research and industry in developing emergent technologies, their role in providing the expertise and talent needed to further the sector, and why digitization is the future of CGT therapies.
What’s in this episode
- 01:00 – Matthew’s career leading up to being CEO at the CGT Catapult
- 02:18 – What the CGT Catapult does and who they work with
- 07:08 – What challenges Matthew see’s facing the CGT industry in the UK
- 10:02 – How the Catapult interacts with the private sector in delivering CGT services
- 12:05 – Matthew’s perspective on decentralized manufacturing for CGTs
- 18:11 – Is digital the future of cell and gene therapies?
- 30:39 – What should innovators be focusing on in the short term?
- 37:11 – How the Catapult is addressing the talent shortage in the CGT industry
- 43:36 – The changes in mindsets that Matthew thinks will help drive the UK CGT industry forward
- 51:26 – Matthew’s predictions for the CGT industry in the next 5-10 years
